Medications

US approves drug for middle-of-the-night insomniacs

The US Food and Drug Administration, for the first time, approved Wednesday medication specifically designed for those who wake up in the middle of the night and cannot fall back to sleep.

Alzheimer's disease & dementia

Early Alzheimer's detection up to 17 years in advance

The dementia disorder Alzheimer's disease has a symptom-free course of 15 to 20 years before the first clinical symptoms emerge. Using an immuno-infrared sensor developed in Bochum, a research team is able to identify signs ...

page 6 from 40